» Articles » PMID: 35906569

Burden, Trends, and Risk Factors for Breast Cancer in China from 1990 to 2019 and Its Predictions Until 2034: an Up-to-date Overview and Comparison with Those in Japan and South Korea

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2022 Jul 29
PMID 35906569
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The difference in epidemiological characteristics of breast cancer (BC) across countries is valuable for BC management and prevention. The study evaluated the up-to-date burden, trends, and risk factors of BC in China, Japan and South Korea during 1990-2019 and predicted the BC burden until 2034.

Methods: Data on incident cases, deaths, disability-adjusted life-years (DALYs) and age-standardized rate (ASR) of BC were extracted from the Global Burden of Disease Study 2019. Trend analysis and prediction until 2034 were conducted by estimated annual percentage change and a Bayesian age-period-cohort model, respectively. Besides, the attributable burden to BC risk factors was also estimated.

Results: In 2019, the number of BC incident cases, deaths and DALYs in China were 375,484, 96,306 and 2,957,453, respectively. The ASR of incidence increased, while that of death and DALYs decreased for Chinese females and Japanese and South Korean males during 1990-2019. High body-mass-index (BMI) was the largest contributor to Chinese female BC deaths and DALYs, while alcohol use was the greatest risk factor for Japanese and South Korean as well as Chinese males. The incident cases and deaths were expected to continue increase during 2020-2034 (except for Japanese female incident cases).

Conclusions: China had the greatest burden of BC among the three countries. Incident cases and deaths of BC were projected to increase over the next 15 years in China, particularly among Chinese males. Effective prevention and management strategies are urgently necessary for BC control in China.

Citing Articles

Global evolution of breast cancer incidence in childbearing-age women aged 15-49 years: a 30-year analysis.

Xia C, Liu Y, Yong W, Qing X J Cancer Res Clin Oncol. 2025; 151(2):75.

PMID: 39932566 PMC: 11814059. DOI: 10.1007/s00432-025-06113-0.


Global, regional, and national burden of seborrheic dermatitis in individuals aged 55 and older from 1990 to 2021: a trend analysis and future projections.

Huang Z, Lin J, Ding Q, Li X, Lin L, Lu T Arch Dermatol Res. 2025; 317(1):381.

PMID: 39922985 DOI: 10.1007/s00403-025-03870-3.


Global regional and national burden of intracerebral hemorrhage between 1990 and 2021.

Wang Z, Wan M, Tai J, Wang Y, Yin M Sci Rep. 2025; 15(1):3624.

PMID: 39880918 PMC: 11779937. DOI: 10.1038/s41598-025-88017-0.


Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021.

Ren W, Guo X, Liu Z, Wu Y, Peng R, Liu H Cancer. 2025; 131(2):e35712.

PMID: 39777671 PMC: 11705200. DOI: 10.1002/cncr.35712.


Global, regional, and national burdens of intracerebral hemorrhage and its risk factors from 1990 to 2021.

Song D, Xu D, Li M, Wang F, Feng M, Badr A Eur J Neurol. 2024; 32(1):e70031.

PMID: 39731311 PMC: 11680743. DOI: 10.1111/ene.70031.


References
1.
Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

2.
Chen X, Ke Z, Chen Y, Lin X . The prevalence of sleep problems among children in mainland China: a meta-analysis and systemic-analysis. Sleep Med. 2021; 83:248-255. DOI: 10.1016/j.sleep.2021.04.014. View

3.
Youlden D, Cramb S, Dunn N, Muller J, Pyke C, Baade P . The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012; 36(3):237-48. DOI: 10.1016/j.canep.2012.02.007. View

4.
Wang Y, Xu M, Ke Z, Luo J . Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer. Pharmacol Res. 2016; 115:299-308. PMC: 5205572. DOI: 10.1016/j.phrs.2016.12.005. View

5.
Ma R . Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018; 61(6):1249-1260. DOI: 10.1007/s00125-018-4557-7. View